The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(3-fluorophenyl)penta-2,4-dienehydrazide ID: ALA5198909
PubChem CID: 168289568
Max Phase: Preclinical
Molecular Formula: C11H11FN2O
Molecular Weight: 206.22
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NNC(=O)/C=C/C=C/c1cccc(F)c1
Standard InChI: InChI=1S/C11H11FN2O/c12-10-6-3-5-9(8-10)4-1-2-7-11(15)14-13/h1-8H,13H2,(H,14,15)/b4-1+,7-2+
Standard InChI Key: KHYOOFXDTCVAKX-BQJQTIKASA-N
Molfile:
RDKit 2D
15 15 0 0 0 0 0 0 0 0999 V2000
3.5726 0.4115 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8581 -0.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1436 0.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1436 1.2366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4291 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 0.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0001 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7141 0.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4288 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1462 0.4133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8581 -0.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8581 -0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1418 -1.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4288 -0.8260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5726 0.4094 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
3 4 2 0
5 3 1 0
6 5 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 9 2 0
11 15 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 206.22Molecular Weight (Monoisotopic): 206.0855AlogP: 1.39#Rotatable Bonds: 3Polar Surface Area: 55.12Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.50CX Basic pKa: 3.29CX LogP: 1.70CX LogD: 1.70Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.26Np Likeness Score: -0.63
References 1. Mavrikaki V, Pagonis A, Poncin I, Mallick I, Canaan S, Magrioti V, Cavalier JF.. (2022) Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives., 64 [PMID:35307568 ] [10.1016/j.bmcl.2022.128692 ]